Turk Ilac ve Serumnayi (IST:TRILC) 3-Year EBITDA Growth Rate : 47.70% (As of Sep. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Turk Ilac ve Serumnayi 3-Year EBITDA Growth Rate?

Turk Ilac ve Serumnayi's EBITDA per Share for the three months ended in Sep. 2023 was ₺0.44.

During the past 12 months, Turk Ilac ve Serumnayi's average EBITDA Per Share Growth Rate was 83.50% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 47.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 49.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 6 years, the highest 3-Year average EBITDA Per Share Growth Rate of Turk Ilac ve Serumnayi was 70.40% per year. The lowest was 27.80% per year. And the median was 47.70% per year.

Competitive Comparison of Turk Ilac ve Serumnayi's 3-Year EBITDA Growth Rate

For the Drug Manufacturers - Specialty & Generic subindustry, Turk Ilac ve Serumnayi's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Turk Ilac ve Serumnayi's 3-Year EBITDA Growth Rate Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Turk Ilac ve Serumnayi's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Turk Ilac ve Serumnayi's 3-Year EBITDA Growth Rate falls into.

Turk Ilac ve Serumnayi 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

Turk Ilac ve Serumnayi (IST:TRILC) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

Turk Ilac ve Serumnayi 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of Turk Ilac ve Serumnayi's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

Turk Ilac ve Serumnayi (IST:TRILC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Turk Ilac ve Serum Sanayi (IST:TRILC) » Definitions » 3-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

N/A

Address

Bügduz Mah. Enver Pasa Cad., No: 8 Akyurt, Ankara, TUR, TR 06750

Website

http://www.turkilac.com.tr

Turk Ilac ve Serum Sanayi is engaged in the production of human pharmaceuticals and vaccines.

Turk Ilac ve Serumnayi (IST:TRILC) Headlines

No Headlines